A collaborative care model of anticoagulation therapy in patients with stroke

Neurology Asia

Volumn 16, Issue 2, 2011, Pages 111-118

  Lee, Tzung Yi ^a   Po, Helen L ^a   Lin, Ya Ju ^a   Tsun, Wen Ju ^a   Wang, Shen Chuan ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ABNORMAL FECES; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GINGIVA BLEEDING; HEALTH CARE QUALITY; HEALTH CENTER; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HEMATURIA; HEMOPTYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MANAGED CARE; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT REFERRAL; RETROSPECTIVE STUDY; RHEUMATIC HEART DISEASE; SKIN BRUISING; STROKE; TREATMENT DURATION; TREATMENT INDICATION;

EID: 79960504862     PISSN: 18236138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract 2001; 14:16-21.
2. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998; 158:1641-7.
3. Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005; 127:1515-22.
4. Bungard TJ, Gardner L, Archer SL, et al. Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care. Open Medicine 2009; 3(1):16-21.
5. th Edition). Chest 2008; 133:S546-92.
6. Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolys 2003; 15:213-16.
7. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37:577-617.
8. Chan FWH, Wong RSM, Lau WH, Chan TYK, Cheng G, You JHS. Management of Chinese patients on warfarin therapy in two models of anticoagulation service-a prospective randomized trial. Br J Clin Pharmacol 2006; 62:601-9.
9. Wilson SJA, Wells PS, Kovacs MJ, et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 2003; 169:293-8.
10. You JH, Chan FW, Wong RS, Cheng G. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br J Clin Pharmacol 2005; 59:582-7.
11. Stroke Prevention in Atrial fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixeddose warfarin plus aspirin for high-risk patients with atrial fibrillation: the stroke prevention in atrial fibrillation III randomized clinical trial. Lancet 1996; 348:633-8.
12. Cheung C-M, Tsoi T-H, Huang C-Y. The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation. Cerebrovasc Dis 2005; 20:114-9.
13. Hylek EM, Skates SJ, Sheehan MA, Singer DE. Analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996; 335:540-6.
14. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349:1019-26.
15. Rose AJ, Ozonoff A, Grant RW, et al. Epidemiology of subtherapeutic anticoagulation in the United States. Circ Cardiovasc Qual Outcomes 2009; 2:591-7.
16. Poon IO, Lal L, Brown EN, Braun UK. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther 2007; 32:21-9.
17. Cryder B, Felczak M, Janociak J, et al. Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics. Journal of Clinical Pharmacy and Therapeutics 2011; 36:64-70.